| 769 |
Physiology-guided Optimal PCI: Learning from DEFINE Trials |
Mitsuaki Matsumura |
Apr. 19. 24 |
| 768 |
What Events Happened in the Physiology Field in 2023? |
Sang Min Park |
Apr. 19. 24 |
| 767 |
What Events Happened in the Imaging Field in 2023? |
Do Hyung Lim |
Apr. 19. 24 |
| 766 |
Novel Approach to FFR-Negative and TCFA-Positive Coronary Lesions: How Can We Mange It? |
Wojciech Wojakowski |
Apr. 19. 24 |
| 765 |
Integration of Image-based Physiology and Plaque Vulnerability: Current and Future |
Shengxian Tu |
Apr. 19. 24 |
| 764 |
Medical Cost and Prognostic Impact of FFR-guided PCI |
Seung Hun Lee |
Apr. 19. 24 |
| 763 |
3-Year Follow-Up of the FAME 3 Trial |
William F. Fearon |
Apr. 19. 24 |
| 762 |
OCT-guided Primary PCI for ACS: Is It Easily Applicable in Practice? |
Junichi Yamaguchi |
Apr. 19. 24 |
| 761 |
High-Risk Plaques on Coronary CT Angiography Correlation with OCT: Invasive vs. Non-Invasive Tools for Vulnerable Plaque |
Junya Ako |
Apr. 19. 24 |
| 760 |
CT-guided PCI is Coming Soon to Your Cath Lab in the Near Future |
Carlos Collet |
Apr. 19. 24 |
